$CBDL CBD Life Sciences Inc. (CBDL) Announces New
Post# of 4788
(Total Views: 45)
Posted On: 05/28/2025 9:19:24 AM
$CBDL CBD Life Sciences Inc. (CBDL) Announces New Powerful 500MG THC Delta-8 Gummy
https://www.accessnewswire.com/newsroom/en/he...-8-1032515
With Delta-8 product revenue continuing to climb, CBDL introduces a lab-tested gummy formulation to meet surging demand in a market projected to exceed $2.1 billion by 2026.
SCOTTSDALE, AZ / ACCESS Newswire / May 28, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a rising force in the cannabinoid wellness industry, is proud to announce the latest addition to its growing Delta-8 product lineup: a premium, lab-tested Delta-8 THC gummy, developed in-house to ensure consistency, potency, and quality at every step.
Building on the success of its existing Delta-8 offerings, this new gummy marks another strategic milestone in CBDL's mission to dominate the cannabinoid edibles market. Crafted in a controlled lab environment, this new edible is designed for consumers who prioritize quality, effectiveness, and a clean, smooth Delta-8 experience.
"We've already seen strong performance across our Delta-8 line, and this gummy is a direct response to customer demand for more convenient, enjoyable, and effective ways to experience its benefits," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "As always, we're delivering a product that's backed by science, produced in-house, and driven by results."
Delta-8 THC: Expanding the Future of Functional Wellness
Unlike traditional Delta-9 THC, Delta-8 offers a milder, clearer psychoactive experience - making it a preferred option for wellness seekers, first-time users, and individuals looking for a balanced high without anxiety.
CBDL's newly formulated Delta-8 gummies are not just about effect - they're designed to deliver real therapeutic value. Below is a breakdown of the core wellness benefits supported by research and consumer feedback:
Pain Relief
• Engages the endocannabinoid system to help regulate pain
• May reduce inflammation that contributes to chronic discomfort
Anxiety & Stress Support
• Natural calming effects to help manage daily stress and reduce anxiety
• Promotes overall mood balance without sedation
Nausea Control
• Anti-emetic potential makes it a powerful option for those undergoing chemotherapy or other nausea-inducing treatments
Appetite Stimulation
• Ideal for individuals with appetite loss or dietary imbalances related to health conditions
Neuroprotective Potential
• Early research suggests Delta-8 THC may contribute to long-term brain health through its interaction with CB1 receptors
Made In-House. Backed by Lab Testing.
Unlike many mass-produced gummies on the market, CBDL maintains full control over every phase - from formulation to packaging - in its in-house manufacturing facility. Each batch is independently lab-tested to guarantee purity, potency, and compliance, giving consumers complete confidence in what they're consuming.
Strategic Growth for Shareholders & Stakeholders
Delta-8 THC products have already proven to be one of CBDL's strongest performing categories, and this launch further solidifies the company's aggressive expansion in the high-growth cannabinoid edible space. The market for Delta-8 continues to gain national momentum, with sales projections showing compound annual growth that far outpaces many traditional supplement sectors.
"This gummy is just one part of a much larger product ecosystem we're building - focused on in-demand cannabinoids, real health outcomes, and market scalability," said Nelson.
Product Details
• Product: Delta-8 THC Gummy
• Type: Vegan, In-House Formulated, Lab-Tested
• MG per Gummy: 500MG
• Availability: Launching via www.thecbdvault.com
• Flavors: Blue Razz & Strawberry
https://www.accessnewswire.com/newsroom/en/he...-8-1032515
With Delta-8 product revenue continuing to climb, CBDL introduces a lab-tested gummy formulation to meet surging demand in a market projected to exceed $2.1 billion by 2026.
SCOTTSDALE, AZ / ACCESS Newswire / May 28, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a rising force in the cannabinoid wellness industry, is proud to announce the latest addition to its growing Delta-8 product lineup: a premium, lab-tested Delta-8 THC gummy, developed in-house to ensure consistency, potency, and quality at every step.
Building on the success of its existing Delta-8 offerings, this new gummy marks another strategic milestone in CBDL's mission to dominate the cannabinoid edibles market. Crafted in a controlled lab environment, this new edible is designed for consumers who prioritize quality, effectiveness, and a clean, smooth Delta-8 experience.
"We've already seen strong performance across our Delta-8 line, and this gummy is a direct response to customer demand for more convenient, enjoyable, and effective ways to experience its benefits," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "As always, we're delivering a product that's backed by science, produced in-house, and driven by results."
Delta-8 THC: Expanding the Future of Functional Wellness
Unlike traditional Delta-9 THC, Delta-8 offers a milder, clearer psychoactive experience - making it a preferred option for wellness seekers, first-time users, and individuals looking for a balanced high without anxiety.
CBDL's newly formulated Delta-8 gummies are not just about effect - they're designed to deliver real therapeutic value. Below is a breakdown of the core wellness benefits supported by research and consumer feedback:
Pain Relief
• Engages the endocannabinoid system to help regulate pain
• May reduce inflammation that contributes to chronic discomfort
Anxiety & Stress Support
• Natural calming effects to help manage daily stress and reduce anxiety
• Promotes overall mood balance without sedation
Nausea Control
• Anti-emetic potential makes it a powerful option for those undergoing chemotherapy or other nausea-inducing treatments
Appetite Stimulation
• Ideal for individuals with appetite loss or dietary imbalances related to health conditions
Neuroprotective Potential
• Early research suggests Delta-8 THC may contribute to long-term brain health through its interaction with CB1 receptors
Made In-House. Backed by Lab Testing.
Unlike many mass-produced gummies on the market, CBDL maintains full control over every phase - from formulation to packaging - in its in-house manufacturing facility. Each batch is independently lab-tested to guarantee purity, potency, and compliance, giving consumers complete confidence in what they're consuming.
Strategic Growth for Shareholders & Stakeholders
Delta-8 THC products have already proven to be one of CBDL's strongest performing categories, and this launch further solidifies the company's aggressive expansion in the high-growth cannabinoid edible space. The market for Delta-8 continues to gain national momentum, with sales projections showing compound annual growth that far outpaces many traditional supplement sectors.
"This gummy is just one part of a much larger product ecosystem we're building - focused on in-demand cannabinoids, real health outcomes, and market scalability," said Nelson.
Product Details
• Product: Delta-8 THC Gummy
• Type: Vegan, In-House Formulated, Lab-Tested
• MG per Gummy: 500MG
• Availability: Launching via www.thecbdvault.com
• Flavors: Blue Razz & Strawberry
(0)
(0)